Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new dominant selectable marker for use in Cryptococcus neoformans.

H C McDade1, G M Cox

  • 1Department of Microbiology, Duke University Medical Center, Durham, NC 27710, USA.

Medical Mycology
|March 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geographic information systems analysis to focus TB screening among people born in endemic countries.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

An objective approach to model reduction: Application to the Sirius wheat model.

Agricultural and forest meteorology·2014
Same author

Identification and characterization of an SKN7 homologue in Cryptococcus neoformans.

Infection and immunity·2005
Same author

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same author

Fungal phospholipase activity and susceptibility to lipid preparations of amphotericin B.

Antimicrobial agents and chemotherapy·2001
Same author

Two cyclophilin A homologs with shared and distinct functions important for growth and virulence of Cryptococcus neoformans.

EMBO reports·2001

Researchers developed a new selectable marker for Cryptococcus neoformans, a fungus causing infections. This nourseothricin resistance marker allows for easier genetic manipulation in studies of fungal pathogenesis.

Area of Science:

  • Mycology
  • Molecular Biology
  • Medical Microbiology

Background:

  • Cryptococcus neoformans is a significant human pathogen and a model for fungal infection research.
  • Existing selectable markers for C. neoformans transformation are limited, necessitating the development of new tools.
  • Genetic manipulation is crucial for understanding the molecular pathogenesis of C. neoformans.

Purpose of the Study:

  • To develop a novel dominant selectable marker for C. neoformans transformation.
  • To assess the utility of nourseothricin resistance for genetic studies in C. neoformans.

Main Methods:

  • Constructed a fusion gene expressing the nourseothricin acetyltransferase gene (nat1) under the control of a C. neoformans actin promoter.
  • Transformed C. neoformans strains (H99 and JEC21) using biolistic delivery of the construct.

Related Experiment Videos

  • Confirmed integration of the construct via Southern blot analysis and assessed resistance profiles.

    • Main Results:

    • Achieved transformation efficiencies of approximately 1,000 transformants/µg DNA (H99) and 20 transformants/µg DNA (JEC21).
    • Confirmed random genomic integration of the nourseothricin resistance construct in transformants.
    • Demonstrated no cross-resistance to hygromycin B, indicating marker independence.

    Conclusions:

    • Nourseothricin resistance serves as an effective second dominant selectable marker for C. neoformans.
    • This new marker facilitates future molecular studies on this important pathogenic fungus.
    • The development enhances the genetic toolkit for C. neoformans research.